Granules India Reports Fourth Quarter And Annual Results
ECONOMY & POLICY

Granules India Reports Fourth Quarter And Annual Results

All monetary figures are in Rs million (mn). Granules India reported results for the fourth quarter and fiscal year ended 31 March 2026. Fourth quarter revenue from operations was Rs 14,706 mn, up 23 per cent year on year, with earnings before interest, tax, depreciation and amortisation of Rs 3,521 mn, up 40 per cent, and profit before tax before exceptional items at Rs 2,464 mn, up 48 per cent; net profit was Rs 2,016 mn, up 33 per cent.\n\nNorth America accounted for 72 per cent of fourth quarter revenue and Europe for 17 per cent. Finished dosages contributed 73 per cent, active pharmaceutical ingredients 13 per cent, pharmaceutical formulation intermediates 9 per cent and Peptides CDMO 5 per cent. Return on capital employed rose to 17.6 per cent in FY26 from 16.6 per cent, and net debt declined to Rs 4,021 mn, down Rs 3,040 mn year on year, leaving net debt to EBITDA at 0.34 times.\n\nOn a yearly basis, consolidated revenue was Rs 53,656 mn, up 20 per cent, with EBITDA of Rs 11,851 mn, up 25 per cent and an EBITDA margin of 22 per cent. Reported net profit for FY26 was Rs 5,950 mn, up 19 per cent year on year, and profit before tax before exceptional items was Rs 7,950 mn.\n\nThe chairman and managing director attributed the results to portfolio expansion, disciplined execution and progress on regulatory, compliance and sustainability initiatives, and noted improved earnings quality alongside advancement in complex generics and the Peptides CDMO platform. Granules India is a vertically integrated pharmaceutical company operating across active pharmaceutical ingredients, pharmaceutical formulation intermediates, finished dosages and Peptides CDMO, and serves more than 300 customers in over 80 countries. The group operates 10 manufacturing facilities, including 7 in India, 2 in the United States and 1 in Switzerland, and holds approvals from multiple regulators.

All monetary figures are in Rs million (mn). Granules India reported results for the fourth quarter and fiscal year ended 31 March 2026. Fourth quarter revenue from operations was Rs 14,706 mn, up 23 per cent year on year, with earnings before interest, tax, depreciation and amortisation of Rs 3,521 mn, up 40 per cent, and profit before tax before exceptional items at Rs 2,464 mn, up 48 per cent; net profit was Rs 2,016 mn, up 33 per cent.\n\nNorth America accounted for 72 per cent of fourth quarter revenue and Europe for 17 per cent. Finished dosages contributed 73 per cent, active pharmaceutical ingredients 13 per cent, pharmaceutical formulation intermediates 9 per cent and Peptides CDMO 5 per cent. Return on capital employed rose to 17.6 per cent in FY26 from 16.6 per cent, and net debt declined to Rs 4,021 mn, down Rs 3,040 mn year on year, leaving net debt to EBITDA at 0.34 times.\n\nOn a yearly basis, consolidated revenue was Rs 53,656 mn, up 20 per cent, with EBITDA of Rs 11,851 mn, up 25 per cent and an EBITDA margin of 22 per cent. Reported net profit for FY26 was Rs 5,950 mn, up 19 per cent year on year, and profit before tax before exceptional items was Rs 7,950 mn.\n\nThe chairman and managing director attributed the results to portfolio expansion, disciplined execution and progress on regulatory, compliance and sustainability initiatives, and noted improved earnings quality alongside advancement in complex generics and the Peptides CDMO platform. Granules India is a vertically integrated pharmaceutical company operating across active pharmaceutical ingredients, pharmaceutical formulation intermediates, finished dosages and Peptides CDMO, and serves more than 300 customers in over 80 countries. The group operates 10 manufacturing facilities, including 7 in India, 2 in the United States and 1 in Switzerland, and holds approvals from multiple regulators.

Next Story
Infrastructure Urban

Panasonic Showcases Connected Display Solutions

Panasonic Life Solutions India showcased its integrated display, projection, broadcast and communication technologies at Panasonic Tech Summit 2026 in New Delhi. Hosted through its System Solutions Division, the two-day event highlighted connected technology solutions for education, healthcare, retail, transportation, corporate offices and entertainment.The summit, themed ‘Turning Technology into Value’, featured experience-led zones covering QSR, retail, transit, corporate offices, healthcare, education, security, projection, home theatre and professional displays. Panasonic also introduc..

Next Story
Infrastructure Transport

Kapsch to Deliver India’s First C-ITS Project

"Kapsch TrafficCom will deliver India’s first Cooperative Intelligent Transport Systems project on a key expressway near New Delhi. The project will be implemented with Superwave Communication And Infrasolution Limited to demonstrate how connected mobility can improve road safety and traffic efficiency.The pilot will use real-time connectivity and AI-enabled situational awareness to support road users, especially in high-risk areas such as temporary work zones. Drivers will receive alerts on roadworks, maintenance vehicles, hazardous locations, traffic queues and temporary virtual signage di..

Next Story
Infrastructure Urban

Eurobond Net Profit Rises 44 Per Cent

Euro Panel Products, the parent company of Eurobond, reported a 44.13 per cent year-on-year rise in net profit for FY25–26. The company’s revenue from operations grew 18.91 per cent to Rs 503.20 crore, compared to Rs 423.18 crore in the previous financial year.The company’s full-year EBITDA stood at Rs 56.67 crore, marking a 31.82 per cent increase. Profit after tax rose to Rs 26.56 crore, while net worth increased 20.15 per cent to Rs 160.07 crore. Earnings per share for the year stood at Rs 10.84.Divyam Rajesh Shah, Whole Time Director and CFO, Euro Panel Products, said the company’s..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

-->